SYS · ONLINEPASS · 63.0%
Open Assay
Independent Testing / Est. 2026
BATCH04·26·B
PASS63.0%
N27

Glossary

Phase 1 trial

First-in-human study. Small sample (20-80 volunteers), focused on safety, tolerability, and pharmacokinetics. Not powered for efficacy.